Arintra, a GenAI-native autonomous medical coding platform for healthcare providers, has raised $21 million in its Series A funding round led by Peak XV Partners.
The round also saw participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors.
The funds raised will be used to expand its adoption across health systems and physician groups nationwide, accelerate product development, scale its team, and open a new Bay Area headquarters.
Founded in 2020 by Nitesh Shroff and Preeti Bhargava, Arintra operates a GenAI-native autonomous medical coding platform for healthcare providers, enabling health systems to receive accurate and efficient payment for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention.
Arintra’s GenAI native platform combines large language models with clinical knowledge graphs to interpret patient charts in context and apply specialty-specific coding guidelines with precision. The platform integrates natively with leading Electronic Health Record systems (EHRs), including Epic and Athena, operating almost invisibly within existing workflows.
Preeti Bhargava, Co-founder and CTO of Arintra, said, “At Arintra, we bring together autonomous medical coding, clinical documentation improvement, and denial prevention in a single platform. By helping providers document what was done, code what was documented, and properly support what was charged, we enable them to secure full, compliant reimbursement at a lower cost, with fewer delays and significantly less manual effort.”
Nitesh Shroff, Co-founder and CEO of Arintra, said, “Reimbursement in healthcare is fundamentally broken. Payers are moving fast, using policy and technology to shift more burden onto providers, but autonomous coding hasn’t kept up. We built Arintra to help healthcare providers secure compliant revenue at scale while easing the burden on frontline teams.”
Mohit Bhatnagar, MD, Peak XV, said, “The disruption of the $150 billion healthcare reimbursements industry will be one of AI’s defining impacts. Arintra’s autonomous system tackles one of the hardest challenges for providers; translating clinical documentation into accurate insurance codes so they get paid fairly and fast. The results speak for themselves; providers are recovering millions in lost revenue by partnering with Arintra. It is a great example of vertical AI done right – real enterprise adoption, clear ROI, and an ambitious roadmap as models continue to improve. After backing Nitesh and Preeti at seed through our Surge Program, Peak XV Partners is excited to double down and lead Arintra’s Series A round.”
